c细胞增生是偶然发现的患者乳头状甲状腺微癌

IF 1.2

International Journal of Endocrine Oncology Pub Date : 2015-11-24 DOI:10.2217/IJE.15.21

D. Nasikas, Michael Sofopoulos, N. Arnogiannaki, G. Sakorafas

引用次数: 1

摘要

c细胞增生(CCH)被认为是一种与各种内分泌疾病相关的肿瘤前病变。传统上分为反应性(良性)CCH和肿瘤性CCH。我们在此报告一例年轻男性，在甲状腺乳头状癌全甲状腺切除术后偶然发现CCH。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

C-cell hyperplasia as an incidental finding in a patient with papillary thyroid microcarcinoma

C-cell hyperplasia (CCH) is considered as a preneoplastic lesion associated with various endocrinopathies. Traditionally it is subdivided into reactive (benign) CCH and neoplastic. We report here a case of a young male, where CCH was an incidental finding after total thyroidectomy for papillary thyroid cancer.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

International Journal of Endocrine Oncology ONCOLOGY-

自引率

0.00%

发文量

审稿时长

13 weeks

期刊介绍： International Journal of Endocrine Oncology is a quarterly, peer-reviewed journal that helps the clinician to keep up to date with best practice in this fast-moving field. The journal highlights significant advances in basic and translational research, and places them in context for future therapy. The journal presents the latest research findings in diagnosis and management of endocrine cancer, together with authoritative reviews, cutting-edge editorials and perspectives that highlight hot topics and controversy in the field. Independent drug evaluations assess newly approved medications and their role in clinical practice. The journal welcomes the unsolicited submission of article proposals and original research manuscripts.